Wegovy (semaglutide) is a GLP-1 receptor agonist that slows gastric emptying, potentially exacerbating pre-existing gastric conditions Common gastrointestinal side effects include nausea (44%), vomiting (24%), dyspepsia, abdominal pain, and constipation Gastritis is not listed as a recognised adverse effect in the UK Summary of Product Characteristics Patients with severe gastrointestinal disease or history of peptic ulcer disease should discuss risks with their prescriber before starting treatment Seek urgent medical advice for severe abdominal pain, vomiting blood, black stools, or persistent symptoms that do not improve Table of Contents Can Wegovy Cause Gastritis
Dont share cold sore creams with anyone
however, the involvement of the mesolimbic dopamine reward system is thought to be indispensable in the pathophysiological route (Figure 2)
To view a copy of this licence, visit About this article Cite this article De Weggheleire, A., De Baetselier, I., An, S